Capital Investment Counsel LLC Has $3.28 Million Stock Position in Sanofi (NASDAQ:SNY)

Capital Investment Counsel LLC boosted its holdings in shares of Sanofi (NASDAQ:SNY) by 2.2% in the fourth quarter, HoldingsChannel reports. The fund owned 67,958 shares of the company’s stock after buying an additional 1,471 shares during the quarter. Capital Investment Counsel LLC’s holdings in Sanofi were worth $3,278,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Dimensional Fund Advisors LP increased its stake in shares of Sanofi by 0.4% in the second quarter. Dimensional Fund Advisors LP now owns 318,760 shares of the company’s stock worth $15,466,000 after acquiring an additional 1,238 shares during the last quarter. AQR Capital Management LLC acquired a new position in Sanofi in the 2nd quarter worth about $344,000. The Manufacturers Life Insurance Company raised its stake in shares of Sanofi by 27.3% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 31,528 shares of the company’s stock worth $1,530,000 after purchasing an additional 6,756 shares in the last quarter. Creative Planning raised its stake in shares of Sanofi by 9.2% during the 2nd quarter. Creative Planning now owns 187,035 shares of the company’s stock worth $9,075,000 after purchasing an additional 15,749 shares in the last quarter. Finally, NewEdge Advisors LLC lifted its holdings in shares of Sanofi by 27.2% during the 2nd quarter. NewEdge Advisors LLC now owns 29,587 shares of the company’s stock valued at $1,436,000 after buying an additional 6,330 shares during the last quarter. Hedge funds and other institutional investors own 14.04% of the company’s stock.

Sanofi Trading Down 0.7 %

Shares of NASDAQ:SNY opened at $52.97 on Wednesday. The company has a current ratio of 1.00, a quick ratio of 0.65 and a debt-to-equity ratio of 0.17. The stock has a market capitalization of $134.43 billion, a PE ratio of 27.03, a P/E/G ratio of 1.19 and a beta of 0.57. Sanofi has a 1 year low of $45.22 and a 1 year high of $58.97. The firm has a fifty day moving average price of $48.90 and a 200 day moving average price of $52.22.

Analysts Set New Price Targets

Separately, StockNews.com lowered shares of Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.